Status:
UNKNOWN
Atrial Fibrillation and Other Cardiac Arrhythmias and Diseases After Radiotherapy for Breast Cancer : Watch Your HeaRT
Lead Sponsor:
Sophie JACOB
Collaborating Sponsors:
Clinique Pasteur Toulouse
Centre Francois Baclesse
Conditions:
Breast Cancer
Radiation Toxicity
Eligibility:
FEMALE
65+ years
Brief Summary
The goal of this interventional study is to evaluate the risk of atrial fibrillation (AF) and other cardiac arrhythmias and diseases in breast cancer patients treated with radiation therapy (RT). In ...
Eligibility Criteria
Inclusion
- Women treated surgically for primary cancer of the left or right breast and for whom adjuvant treatment is RT with irradiation of the breast or chest wall and possibly irradiation of lymph node chains,
- Adjuvant radiotherapy performed at Clinique Pasteur between 2018 and 2020,
- 5-year post-RT follow-up radiation oncologist consultation performed at Clinique Pasteur
- Age ≥ 65 years at the time of the 5-year post-RT follow-up consultation
- Own a smartphone and able to understand and use digital tools alone and/or with the help of a caregiver ;
- Patient having consented to connected follow-up,
- Be affiliated to a social security scheme or equivalent
- Be willing to participate in the study and have signed the consent form
Exclusion
- History of cancer before breast cancer RT
- Recurrence of breast cancer or other cancer treated after breast cancer RT
- History of atrial fibrillation prior to breast cancer RT
Key Trial Info
Start Date :
October 25 2023
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
November 20 2025
Estimated Enrollment :
200 Patients enrolled
Trial Details
Trial ID
NCT06073509
Start Date
October 25 2023
End Date
November 20 2025
Last Update
November 8 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Clinique Pasteur
Toulouse, France